TARO Share Price

Open 115.00 Change Price %
High 116.71 1 Day 1.51 1.31
Low 112.29 1 Week 10.42 9.80
Close 116.71 1 Month 12.25 11.73
Volume 93612 1 Year -19.72 -14.45
52 Week High 152.30
52 Week Low 92.28
TARO Important Levels
Resistance 2 120.81
Resistance 1 119.12
Pivot 115.24
Support 1 114.30
Support 2 112.61
NYSE USA Most Active Stocks
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
BAC 24.52 -0.24%
BAC 24.52 -0.24%
BAC 24.52 -0.24%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
WSH 47.18 -2.86%
More..
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
DGI 35.00 18.24%
DGI 35.00 18.24%
DGI 35.00 18.24%
DGI 35.00 18.24%
IMN 0.78 16.42%
IMN 0.78 16.42%
IMN 0.78 16.42%
UN 48.79 15.29%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Taro Pharmaceutical Industries Ltd. (NYSE: TARO)

TARO Technical Analysis 2
As on 17th Feb 2017 TARO Share Price closed @ 116.71 and we RECOMMEND Sell for LONG-TERM with Stoploss of 124.08 & Strong Buy for SHORT-TERM with Stoploss of 105.81 we also expect STOCK to react on Following IMPORTANT LEVELS.
TARO Target for February
1st Target up-side 110.47
2nd Target up-side 114.66
3rd Target up-side 118.85
1st Target down-side 98.51
2nd Target down-side 94.32
3rd Target down-side 90.13
TARO Other Details
Segment EQ
Market Capital 2088630144.00
Sector Healthcare
Industry Drug Manufacturers - Other
Offical website http://www.taro.com
TARO Address
TARO
14 Hakitor Street
PO Box 10347
Haifa Bay, 26110
Israel
Phone: 972 4 847 5700
TARO Latest News
Interactive Technical Analysis Chart Taro Pharmaceutical Industries Ltd. ( TARO NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Taro Pharmaceutical Industries Ltd.
TARO Business Profile
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, together with its subsidiaries, engages in the research, development, production, and marketing of pharmaceutical products primarily in the United States, Canada, and Israel. It offers prescription and over-the-counter pharmaceutical products focusing on primary areas comprising topical creams and ointments, liquids, capsules, and tablets principally in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company also develops and manufactures active pharmaceutical ingredients for use in its finished dosage form products. Taro Pharmaceutical Industries Ltd. sells and distributes its products to drug wholesalers and store chains, generic drug distributors, mass merchandisers, food and retail chains, and managed care organizations. The company was founded in 1959 and is based in Haifa Bay, Israel.